MedPath

Intravenous Versus Intra-peritoneal Dexamethasone on the Incidence of Postoperative Nausea and Vomiting

Not Applicable
Completed
Conditions
Postoperative Nausea and Vomiting
Interventions
Drug: Intraperitoneal Dexamesathone
Registration Number
NCT02947672
Lead Sponsor
Assiut University
Brief Summary

Effect of intravenous versus intra-peritoneal dexamethasone on the incidence of postoperative nausea and vomiting following Laparoscopic gynecological surgeries.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
100
Inclusion Criteria
  1. Adult Female patients
  2. American society of anesthesiologist class I & II
  3. Undergoing Laparoscopic gynecological surgeries
Exclusion Criteria
  1. Patient refusal to participate in the study
  2. Patients with coagulopathy or under anticoagulation therapy.
  3. Infection near the site of needle insertion.
  4. Body mass index > 40kg/m2
  5. Patients with any neurological or neuromuscular disorder or history of seizures.
  6. Known allergy to any drug used in the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intravenous dexamethasoneIntravenous Dexamethasone50 patients will receive intravenous dexamethasone
Intra peritoneal dexamethasoneIntraperitoneal Dexamesathone50 patients will receive intraperitoneal dexamethasone
Primary Outcome Measures
NameTimeMethod
Postoperative nausea and vomiting (PONV)24 hours

PONV will be measured by using Verbal Descriptive Scale

Secondary Outcome Measures
NameTimeMethod
Pain24 hours

Pain will be assessed by using visual analogue scale

Trial Locations

Locations (1)

Assiut University Hospital

🇪🇬

Assiut, Egypt

© Copyright 2025. All Rights Reserved by MedPath